Andén N E, Grabowska-Andén M
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
J Pharm Pharmacol. 1989 Jul;41(7):490-2. doi: 10.1111/j.2042-7158.1989.tb06508.x.
The motor activity of reserpine-treated mice was used to study effects of B-HT 958 (2-amino-6-(p-chlorobenzyl)-4H-5,6,7,8-tetrahydrothiazolo-[5,4-d]- azepine) on postsynaptic dopamine and noradrenaline receptors. The motor activity was only slightly stimulated by B-HT 958 or by the D1- receptor agonist SKF 38393 but it was markedly increased by the two drugs given in combination. The effect of B-HT 958 peaked earlier following low rather than high doses. The enhanced motor activity was inhibited by the D2- receptor antagonist sulpiride or the D1- receptor antagonist SCH 23390, indicating that it was caused by stimulation of both receptor types. The results suggest that B-HT 958 stimulates postsynaptic D2- receptors in addition to D2- autoreceptors and that its blockade of postsynaptic alpha 2-adrenoceptors is of no importance for the motor activity.
利血平处理过的小鼠的运动活性被用于研究B-HT 958(2-氨基-6-(对氯苄基)-4H-5,6,7,8-四氢噻唑并-[5,4-d]-氮杂卓)对突触后多巴胺和去甲肾上腺素受体的作用。B-HT 958或D1受体激动剂SKF 38393仅轻微刺激运动活性,但两种药物联合使用时运动活性显著增加。低剂量时B-HT 958的作用峰值出现得比高剂量时更早。增强的运动活性被D2受体拮抗剂舒必利或D1受体拮抗剂SCH 23390抑制,表明其是由两种受体类型的刺激引起的。结果表明,B-HT 958除了刺激D2自身受体外,还刺激突触后D2受体,并且其对突触后α2肾上腺素受体的阻断对运动活性并不重要。